On May 4, 2021, HCA Healthcare, Inc. announced that at its annual shareholders meeting held on April 28, 2021, a stockholder proposal requesting a report on the feasibility of increasing the impact of quality metrics on executive compensation as described in the Company’s 2021 proxy statement was not approved.